Single Assay Cholesterol Sub-Fraction Measurement via Kinetic Enzyme Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for measuring cholesterol sub-fractions in blood plasma are inaccurate and require multiple assays, leading to increased costs and errors due to the need for physical separation techniques like centrifugation and electrophoresis.

Innovation Solution

A single assay method using a combination of lipase, oxidase, and peroxidase enzymes that convert cholesterol-containing lipoproteins to measurable products at different rates, allowing for the kinetic differentiation and measurement of HDL-C, LDL-C, and VLDL-C without precipitation or separation steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If physical separation techniques like centrifugation and electrophoresis are used to measure cholesterol sub-fractions, then measurement precision can be improved, but device complexity and loss of time increase

Engineering Contradiction:
Improvecholesterol sub-fraction measurement accuracyVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the measurement of different cholesterol sub-fractions (HDL-C, LDL-C, VLDL-C) from the complex physical separation process by using selective enzyme inhibition. Specific enzymes are inhibited by particular substances to measure each sub-fraction independently in a single assay mixture, eliminating the need for centrifugation and electrophoresis equipment.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a universal assay system where a single reaction mixture can measure multiple cholesterol sub-fractions simultaneously. The same basic enzymatic reaction system, combined with selective inhibitors, serves as a multi-functional platform for determining HDL-C, LDL-C, and VLDL-C without requiring separate measurement systems or separation apparatus.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If multiple assays are performed to measure cholesterol sub-fractions, then measurement precision improves, but loss of time and productivity decrease

Engineering Contradiction:
Improvecholesterol sub-fraction measurement accuracyVSAvoidassay time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent merges the measurement of multiple cholesterol sub-fractions into a single assay procedure. By combining multiple enzymatic reactions in one reaction mixture and using selective inhibition strategies, the system determines HDL-C, LDL-C, and VLDL-C simultaneously, eliminating the need for sequential separate assays and reducing total measurement time.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent performs preliminary enzymatic reactions to convert different cholesterol sub-fractions into measurable forms before the actual measurement step. Enzymes such as lipoprotein lipase and hepatic triglyceride lipase are used in advance to hydrolyze triglycerides and prepare cholesterol esters for subsequent oxidative reactions, enabling rapid simultaneous determination of multiple sub-fractions.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If multiple assays are performed to measure cholesterol sub-fractions, then measurement precision improves, but device complexity and costs increase

Engineering Contradiction:
Improvecholesterol sub-fraction measurement accuracyVSAvoidnumber of assays required
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent merges the measurement of multiple cholesterol sub-fractions into a single assay procedure. By combining multiple enzymatic reactions in one reaction mixture and using selective inhibition strategies, the system determines HDL-C, LDL-C, and VLDL-C simultaneously, eliminating the need for sequential separate assays and reducing total measurement time.

Inventive Principle:
Principle #5Merging (Combining)

4Measurement precision

If physical separation techniques are used, then measurement precision improves, but loss of substance increases

Engineering Contradiction:
Improvecholesterol sub-fraction measurement accuracyVSAvoidblood sample volume
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

The patent creates a universal assay system where a single reaction mixture can measure multiple cholesterol sub-fractions simultaneously. The same basic enzymatic reaction system, combined with selective inhibitors, serves as a multi-functional platform for determining HDL-C, LDL-C, and VLDL-C without requiring separate measurement systems or separation apparatus.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides accurate and precise measurements of cholesterol sub-fractions in a single assay, reducing errors and costs by eliminating the need for multiple assays and physical separation techniques.

Implementation Method 1

A single assay method using a combination of lipase, oxidase, and peroxidase enzymes that convert cholesterol-containing lipoproteins to measurable products at different rates

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

A single assay method using a combination of lipase, oxidase, and peroxidase enzymes that convert cholesterol-containing lipoproteins to measurable products

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

convert cholesterol-containing lipoproteins to measurable products

Methodology Applied
Scientific EffectColorimetric detection: Absorption Spectroscopy

Data Source

PatentUS11268130B2Rapid, low-sample-volume cholesterol and triglyceride assays
Publication Date: 2022.03.08 LABRADOR DIAGNOSTICS LLC
  • US11268130B2 patent drawing
  • US11268130B2 patent drawing
  • US11268130B2 patent drawing

AI summary

Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed. Assays may be performed in a single reaction mixture, allowing more accurate and precise cholesterol determinations, including ratios of cholesterol sub-fractions to total cholesterol, at less expense, than would be expected by performing several different assays in different reaction mixtures.